Evaluation of multiple comparison correction procedures in drug assessment studies using LORETA maps
暂无分享,去创建一个
Monica Rojas-Martínez | Miguel Angel Mañanas | Sergio Romero | Joan Francesc Alonso | J. F. Alonso | Manel J. Barbanoj | Jordi Riba | S. Romero | M. Rojas-Martínez | J. Riba | M. Barbanoj | M. Mañanas
[1] P. Nunez,et al. Electric fields of the brain , 1981 .
[2] Edward M. Cross,et al. Use of the Binomial Theorem in Interpreting Results of Multiple Tests of Significance , 1982 .
[3] Bernd Saletu,et al. Artifact processing in topographic mapping of electroencephalographie activity in neuropsychopharmacology , 1992, Psychiatry Research: Neuroimaging.
[4] Bernd Saletu,et al. Topographic pharmaco‐EEG mapping of increasing doses of buspirone and its comparison with diazepam , 1994 .
[5] Y. Benjamini,et al. Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .
[6] Eric Moulines,et al. A blind source separation technique using second-order statistics , 1997, IEEE Trans. Signal Process..
[7] Thomas E. Nichols,et al. Statistical limitations in functional neuroimaging. II. Signal detection and statistical inference. , 1999, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.
[8] John Suckling,et al. Global, voxel, and cluster tests, by theory and permutation, for a difference between two groups of structural MR images of the brain , 1999, IEEE Transactions on Medical Imaging.
[9] Roberto D. Pascual-Marqui,et al. Effect of the 5-HT1A partial agonist buspirone on regional brain electrical activity in man: a functional neuroimaging study using low-resolution electromagnetic tomography (LORETA) , 2000, Psychiatry Research: Neuroimaging.
[10] R D Pascual-Marqui,et al. Standardized low-resolution brain electromagnetic tomography (sLORETA): technical details. , 2002, Methods and findings in experimental and clinical pharmacology.
[11] I. Johnsrude,et al. The problem of functional localization in the human brain , 2002, Nature Reviews Neuroscience.
[12] Thomas E. Nichols,et al. Nonparametric permutation tests for functional neuroimaging: A primer with examples , 2002, Human brain mapping.
[13] Thomas E. Nichols,et al. Thresholding of Statistical Maps in Functional Neuroimaging Using the False Discovery Rate , 2002, NeuroImage.
[14] Thomas E. Nichols,et al. Controlling the familywise error rate in functional neuroimaging: a comparative review , 2003, Statistical methods in medical research.
[15] E. Bullmore,et al. Human pharmacological MRI. , 2004, Trends in pharmacological sciences.
[16] Thomas E. Nichols,et al. Combining voxel intensity and cluster extent with permutation test framework , 2004, NeuroImage.
[17] P. Anderer,et al. Effects of the South American Psychoactive Beverage Ayahuasca on Regional Brain Electrical Activity in Humans: A Functional Neuroimaging Study Using Low-Resolution Electromagnetic Tomography , 2004, Neuropsychobiology.
[18] B. Saletu,et al. EEG-tomographic studies with LORETA on vigilance differences between narcolepsy patients and controls and subsequent double-blind, placebo-controlled studies with modafinil , 2004, Journal of Neurology.
[19] A. Massey,et al. Effects of DHEA administration on episodic memory, cortisol and mood in healthy young men: a double-blind, placebo-controlled study , 2006, Psychopharmacology.
[20] Bernd Saletu,et al. EEG Topography and Tomography (LORETA) in the Classification and Evaluation of the Pharmacodynamics of Psychotropic Drugs , 2006, Clinical EEG and neuroscience.
[21] G. Buzsáki. Rhythms of the brain , 2006 .
[22] Claudio Del Percio,et al. Frontal white matter volume and delta EEG sources negatively correlate in awake subjects with mild cognitive impairment and Alzheimer's disease , 2006, Clinical Neurophysiology.
[23] Brent R Logan,et al. An evaluation of spatial thresholding techniques in fMRI analysis , 2008, Human brain mapping.
[24] Steven C.R. Williams,et al. Application of Pharmacological MRI to Preclinical Drug Discovery and Development , 2008 .
[25] P. Anderer,et al. Double‐blind, placebo‐controlled, multiple‐ascending‐dose study on the effects of ABIO‐08/01, a novel anxiolytic drug, on perception and cognition, utilizing event‐related potential mapping and low‐resolution brain electromagnetic tomography , 2008, Human psychopharmacology.
[26] Miguel Angel Mañanas,et al. A comparative study of automatic techniques for ocular artifact reduction in spontaneous EEG signals based on clinical target variables: A simulation case , 2008, Comput. Biol. Medicine.
[27] Dietrich Lehmann,et al. Rivastigmine effects on EEG spectra and three-dimensional LORETA functional imaging in Alzheimer’s disease , 2008, Psychopharmacology.
[28] Pavel Mohr,et al. LORETA Functional Imaging in Antipsychotic-Naive and Olanzapine-, Clozapine- and Risperidone-Treated Patients with Schizophrenia , 2008, Neuropsychobiology.
[29] Miguel A Mañanas,et al. Influence of ocular filtering in EEG data on the assessment of drug‐induced effects on the brain , 2009, Human brain mapping.
[30] Michael Wolzt,et al. Double-Blind, Placebo-Controlled, Multiple-Ascending-Dose Study on the Pharmacodynamics of ABIO-08/01, a New CNS Drug with Potential Anxiolytic Activity , 2009, Neuropsychobiology.